VARIANTYX  POSTS

Disease predisposition risk: what to consider beyond cancer

Today, we’re taking a look at disease predisposition risk for conditions other than cancer with a focus on hemochromatosis and alpha-1 trypsin deficiency.

Read More

Cancer predisposition variants: looking beyond BRCA1/2

It’s important to understand that direct-to-consumer testing services like 23andMe and others look at only a small number of variants for each condition. For BRCA1 and BRCA2, that number can be as low as only 3 variants when thousands more have been identified.

Read More

September is Healthy Aging Month!

Because it’s never too early or too late to ensure we’re on the right path with our health, we’re using the Healthy Aging Month campaign to take a look at the important benefits of proactive genetic testing.

Read More

Spotlight on Huntington’s disease

Huntington’s disease is caused by expansion of the CAG repeat in the Huntington (HTT) gene, which is one of more than 20 tandem repeat expansions analyzed by the Genomic Unity™ test.

Read More

Spotlight on hereditary peripheral neuropathies

There are a number of neuropathies that are genetic in origin. They may be inherited in an autosomal dominant, autosomal recessive or X-linked manor. They may also arise de novo.

Read More

Variantyx Inc.

1671 Worcester Road, Suite 300
Framingham MA 01701 USA

Phone: +1 617-209-2090

  • This site is protected by reCAPTCHA and the Google Privacy and Terms of Service apply

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: